What challenges does KLBD certification of pharmaceutical products face?

Pharmaceutical products have complex raw material compositions and some excipients may involve non-kosher ingredients; production stages need to strictly avoid cross-contamination; and the certification process has stringent requirements for documentation standards and process transparency. SINOQUAL, authorized since 2010 as the KLBD Asia-Pacific general agency office, worked with KLBD experts to check the declared products'' raw materials one by one to ensure full-chain compliance, and helped improve the linking documentation and provide standardized guidance on production processes, ensuring process records were traceable and verifiable.

Shaoxing Jingxin Pharmaceutical Obtains KLBD Kosher + Indonesia BPJPH Dual Certification

Shaoxing Jingxin Pharmaceutical Co., Ltd. - BPJPH and KLBD. Precise empowerment: SINOQUAL helps Shaoxing Jingxin Pharmaceutical secure Europe's KLBD KOSHER and Indonesia's official BPJPH HALAL dual certification, opening the door to the global high-end pharmaceutical market. Kosher certification is an independent international quality standard that is increasingly common in food ingredients and retail. Walk into any supermarket in North America or Europe and you will see that a large portion of foods and beverages are kosher-certified. In the pharmaceutical export field, Kosher certification has also gradually become a "golden key" for enterprises to open overseas markets.

Shaoxing Jingxin Pharmaceutical Co., Ltd. - BPJPH and KLBD

Precise empowerment: SINOQUAL helps Shaoxing Jingxin Pharmaceutical secure Europe''s KLBD KOSHER and Indonesia''s official BPJPH HALAL dual certification, opening the door to the global high-end pharmaceutical market

Kosher certification is an independent international quality standard that is increasingly common in food ingredients and retail. Walk into any supermarket in North America or Europe and you will see that a large portion of foods and beverages are kosher-certified. In the pharmaceutical export field, Kosher certification has also gradually become a "golden key" for enterprises to open overseas markets.

As a benchmark enterprise in China''s pharmaceutical industry, Shaoxing Jingxin Pharmaceutical Co., Ltd. planned to obtain the globally recognized KLBD kosher certification in order to further expand its high-end markets in Europe and the Americas. As the largest kosher body in Europe, KLBD has operated for more than a century, is respected and accepted by parties around the world, and its certification mark is widely recognized by manufacturers and consumers globally.

However, KLBD certification of pharmaceutical products faces multiple challenges: raw material compositions are complex and some excipients may involve non-kosher ingredients; production stages need to strictly avoid cross-contamination; and the certification process has stringent requirements for documentation standards and process transparency. Shaoxing Jingxin Pharmaceutical urgently needed a professional certification partner to crack the technical difficulties and efficiently advance the certification process. After extensive evaluation, Shaoxing Jingxin found that as early as 2010, SINOQUAL had been authorized as the Asia-Pacific regional general agency office of the KLBD Kosher certification body. Over the years it has accumulated rich certification-service experience and global resource advantages in the pharmaceutical field, having successfully served pharmaceutical companies such as Sinopharm Group, North China Pharmaceutical, and Zhejiang NHU - making it Shaoxing Jingxin''s first choice for cooperation.

To help Shaoxing Jingxin Pharmaceutical obtain the "passport" to the international high-end pharmaceutical market, SINOQUAL assembled a dedicated service team, providing Jingxin Pharmaceutical with a full-process customized certification plan, precisely tackling the key bottlenecks of KLBD certification. It worked with KLBD experts to check the raw materials of Shaoxing Jingxin''s declared products one by one, ensuring full-chain compliance of the raw materials. At the same time, it helped the enterprise improve the documentation linking to the Kosher standard and provided standardized guidance on production processes, ensuring that process records were traceable and verifiable.

Through the collaboration of both parties, Shaoxing Jingxin Pharmaceutical successfully secured the KLBD kosher certification certificate. This certificate not only proves that its products meet Jewish dietary requirements, but, leveraging KLBD''s global credibility, also opens the door to the high-end pharmaceutical markets of Europe and the Americas. At the same time, to comfortably respond to Indonesia''s mandatory Halal certification policy for pharmaceutical products before October 2026, Shaoxing Jingxin Pharmaceutical, together with SINOQUAL, successfully obtained the BPJPH Halal certification. With dual certification in hand, Shaoxing Jingxin''s overseas journey gains an added layer of assurance!

From raw material review to certificate delivery, SINOQUAL, with its service philosophy of being professional, focused, and dedicated, once again demonstrated its leading advantages in Halal & Kosher certification services in the pharmaceutical field. In the future, SINOQUAL will continue to leverage its global certification resources and technical accumulation to help more Chinese pharmaceutical companies break through trade barriers and achieve an upgrade in international brand value.

FAQ

Which certifications did Shaoxing Jingxin Pharmaceutical obtain?: It secured Europe''s KLBD Kosher certification and Indonesia''s official BPJPH Halal dual certification, opening the door to the global high-end pharmaceutical market. Jingxin Pharmaceutical is a benchmark enterprise in China''s pharmaceutical industry; the dual certification both expands its high-end markets in Europe and the Americas and responds to Indonesia''s mandatory Halal certification policy for pharmaceutical products before October 2026.
What challenges does KLBD certification of pharmaceutical products face?: Pharmaceutical products have complex raw material compositions and some excipients may involve non-kosher ingredients; production stages need to strictly avoid cross-contamination; and the certification process has stringent requirements for documentation standards and process transparency. SINOQUAL, authorized since 2010 as the KLBD Asia-Pacific general agency office, worked with KLBD experts to check the declared products'' raw materials one by one to ensure full-chain compliance, and helped improve the linking documentation and provide standardized guidance on production processes, ensuring process records were traceable and verifiable.